Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 27.
doi: 10.1002/mds.70093. Online ahead of print.

Altered Dopamine Metabolism and Response to Treatment with Levodopa/Carbidopa in MCT8 Deficiency

Fabio Bruschi  1   2 , Ylenia Vaia  1   2 , Clara E Antonello  1 , Marco Spada  3 , Francesco Porta  3   4 , Cristina Marinaccio  5 , Claudia Carducci  6 , Thomas Opladen  7 , Jacopo Sartorelli  8 , Federica Maria Zibordi  9 , Daniele Ghezzi  10   11 , Francesco Nicita  8 , Davide Tonduti  1   2
Affiliations

Altered Dopamine Metabolism and Response to Treatment with Levodopa/Carbidopa in MCT8 Deficiency

Fabio Bruschi et al. Mov Disord. .

Abstract

Background: Allan-Herndon-Dudley syndrome (AHDS)/monocarboxylate transporter 8 (MCT8) deficiency is a rare X-linked encephalopathy caused by SLC16A2 variants, impairing thyroid hormone (TH) transport into the brain. This leads to early central nervous system (CNS) TH deficiency, affecting brain maturation. Dopaminergic circuit involvement is suggested by both pathophysiology and clinical features, reminiscent of infantile parkinsonism.

Objective: This study investigates dopamine metabolism and levodopa/carbidopa response in MCT8 patients.

Methods: We retrospectively and prospectively collected clinical, genetic, and neuroimaging data, performed cerebrospinal fluid (CSF) biogenic amine analyses, and conducted neurological assessments before and after the levodopa trial (10 mg/kg/day).

Results: Ten patients exhibited developmental delay, spasticity, and infantile parkinsonism. CSF analysis showed reduced homovanillic acid in 3/10 patients, with 7/10 in the lowest quartile. Levodopa improved parkinsonism and reactivity in 7/10 patients.

Conclusions: Our findings confirm dopaminergic involvement in AHDS and show that levodopa/carbidopa effectively treats extrapyramidal symptoms. Further investigations could differentiate presynaptic and postsynaptic defects to optimize dopaminergic therapy. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Keywords: Allan‐Herndon‐Dudley syndrome; MCT8; SLC16A2; dystonia; hypothyroidism; neurotransmitter; parkinsonism.

PubMed Disclaimer

References

    1. Groeneweg S, van Geest FS, Abacı A, et al. Disease characteristics of MCT8 deficiency: an international, retrospective, multicentre cohort study. Lancet Diabetes Endocrinol 2020;8(7):594–605.
    1. van Geest FS, Gunhanlar N, Groeneweg S, Visser WE. Monocarboxylate transporter 8 deficiency: from pathophysiological understanding to therapy development. Front Endocrinol 2021;12:723–750.
    1. Tonduti D, Vanderver A, Berardinelli A, et al. MCT8 deficiency: extrapyramidal symptoms and delayed myelination as prominent features. J Child Neurol 2013;28(6):795–800.
    1. Heuer H, Maier MK, Iden S, Mittag J, Friesema ECH, Visser TJ, Bauer K. The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone‐sensitive neuron populations. Endocrinology 2005;146(4):1701–1706.
    1. van Geest FS, Groeneweg S, Visser WE. Monocarboxylate transporter 8 deficiency: update on clinical characteristics and treatment. Endocrine 2021;71:689–695.

LinkOut - more resources